Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

1.

[Introduction of Self-made Software on Radiological Technology].

Kato H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(1):104-110. doi: 10.6009/jjrt.2019_JSRT_75.1.104. Japanese. No abstract available.

2.

The rice ethylene response factor OsERF83 positively regulates disease resistance to Magnaporthe oryzae.

Tezuka D, Kawamata A, Kato H, Saburi W, Mori H, Imai R.

Plant Physiol Biochem. 2019 Feb;135:263-271. doi: 10.1016/j.plaphy.2018.12.017. Epub 2018 Dec 20.

PMID:
30590260
3.

Ce4+-Based Compounds Capable of Photoluminescence by Charge Transfer Excitation under Near-Ultraviolet-Visible Light.

Wen D, Kato H, Kobayashi M, Yamamoto S, Mitsuishi M, Fujii K, Yashima M, Kakihana M.

Inorg Chem. 2018 Nov 12. doi: 10.1021/acs.inorgchem.8b01900. [Epub ahead of print]

PMID:
30417640
4.

Pathogenesis of Atypical Hemolytic Uremic Syndrome.

Yoshida Y, Kato H, Ikeda Y, Nangaku M.

J Atheroscler Thromb. 2019 Feb 1;26(2):99-110. doi: 10.5551/jat.RV17026. Epub 2018 Nov 2.

5.

Functional identification of a rice trehalase gene involved in salt stress tolerance.

Islam MO, Kato H, Shima S, Tezuka D, Matsui H, Imai R.

Gene. 2019 Feb 15;685:42-49. doi: 10.1016/j.gene.2018.10.071. Epub 2018 Oct 26.

PMID:
30393190
6.

Photoluminescence Properties of Layered Perovskite-Type Strontium Scandium Oxyfluoride Activated With Mn4.

Kato H, Takeda Y, Kobayashi M, Kobayashi H, Kakihana M.

Front Chem. 2018 Oct 4;6:467. doi: 10.3389/fchem.2018.00467. eCollection 2018.

7.

Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.

Ito S, Hidaka Y, Inoue N, Kaname S, Kato H, Matsumoto M, Miyakawa Y, Mizuno M, Okada H, Shimono A, Matsuda T, Maruyama S, Fujimura Y, Nangaku M, Kagami S.

Clin Exp Nephrol. 2019 Jan;23(1):112-121. doi: 10.1007/s10157-018-1610-2. Epub 2018 Jul 23.

8.

Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.

Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H.

Clin Exp Nephrol. 2019 Jan;23(1):65-75. doi: 10.1007/s10157-018-1609-8. Epub 2018 Jun 29.

9.

Multiband Imaging CMOS Image Sensor with Multi-Storied Photodiode Structure .

Takemoto Y, Tsukimura M, Kato H, Suzuki S, Aoki J, Kondo T, Saito H, Gomi Y, Matsuda S, Tadaki Y.

Sensors (Basel). 2018 May 24;18(6). pii: E1688. doi: 10.3390/s18061688.

10.

Undoped Layered Perovskite Oxynitride Li2 LaTa2 O6 N for Photocatalytic CO2 Reduction with Visible Light.

Oshima T, Ichibha T, Qin KS, Muraoka K, Vequizo JJM, Hibino K, Kuriki R, Yamashita S, Hongo K, Uchiyama T, Fujii K, Lu D, Maezono R, Yamakata A, Kato H, Kimoto K, Yashima M, Uchimoto Y, Kakihana M, Ishitani O, Kageyama H, Maeda K.

Angew Chem Int Ed Engl. 2018 Jul 2;57(27):8154-8158. doi: 10.1002/anie.201803931. Epub 2018 May 30.

11.

Functional splicing analysis in an infantile case of atypical hemolytic uremic syndrome caused by digenic mutations in C3 and MCP genes.

Yamamura T, Nozu K, Ueda H, Fujimaru R, Hisatomi R, Yoshida Y, Kato H, Nangaku M, Miyata T, Sawai T, Minamikawa S, Kaito H, Matsuo M, Iijima K.

J Hum Genet. 2018 Jun;63(6):755-759. doi: 10.1038/s10038-018-0436-9. Epub 2018 Mar 19.

PMID:
29556035
12.

[Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab].

Fukasawa C, Ooishi S, Kumagai T, Koshiisi M, Sueki Y, Nakajima K, Mitsumori T, Yoshida Y, Kato H, Nangaku M, Miyata T, Kirito K.

Rinsho Ketsueki. 2018;59(2):182-186. doi: 10.11406/rinketsu.59.182. Japanese.

PMID:
29515071
13.

Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome.

Fujisawa M, Kato H, Yoshida Y, Usui T, Takata M, Fujimoto M, Wada H, Uchida Y, Kokame K, Matsumoto M, Fujimura Y, Miyata T, Nangaku M.

Clin Exp Nephrol. 2018 Oct;22(5):1088-1099. doi: 10.1007/s10157-018-1549-3. Epub 2018 Mar 6.

PMID:
29511899
14.

The response of common marmoset immunity against cedar pollen extract.

Kametani Y, Yamada Y, Takabayashi S, Kato H, Ishiwata K, Watanabe N, Sasaki E, Habu S.

Biosci Trends. 2018 Mar 18;12(1):94-101. doi: 10.5582/bst.2017.01219. Epub 2018 Jan 15.

15.

Controversies of the classification of TMA and the terminology of aHUS.

Kato H, Nangaku M, Okada H, Kagami S.

Clin Exp Nephrol. 2018 Aug;22(4):979-980. doi: 10.1007/s10157-017-1524-4. Epub 2017 Dec 27. No abstract available.

PMID:
29282571
16.

Effects of the SrTiO3 support on visible-light water oxidation with Co3O4 nanoparticles.

Okazaki M, Eguchi M, Uchiyama T, Lu D, Kato H, Uchimoto Y, Kakihana M, Maeda K.

Dalton Trans. 2017 Dec 12;46(48):16959-16966. doi: 10.1039/c7dt03444j.

PMID:
29177327
17.

Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.

Clin Exp Nephrol. 2018 Feb;22(1):85-86. doi: 10.1007/s10157-017-1461-2. No abstract available.

PMID:
28875480
18.

Low signal intensity lesions on brain susceptibility-weighted MRI in a patient with intravascular large B-cell lymphoma.

Tsuda Y, Oguri T, Sakurai K, Kajiguchi T, Kato H, Yuasa H.

Rinsho Shinkeigaku. 2017 Sep 30;57(9):504-508. doi: 10.5692/clinicalneurol.cn-001027. Epub 2017 Aug 11. Japanese.

PMID:
28804112
19.

Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.

Clin Exp Nephrol. 2018 Feb;22(1):78-84. doi: 10.1007/s10157-017-1427-4. Epub 2017 Jun 28. Erratum in: Clin Exp Nephrol. 2017 Sep 5;:.

20.

Three cases of posterior reversible encephalopathy syndrome with chronic kidney disease triggered by infection.

Nasu K, Fujisawa M, Kato H, Nangaku M.

Nephrology (Carlton). 2017 Apr;22(4):322-325. doi: 10.1111/nep.12930.

PMID:
28247519

Supplemental Content

Loading ...
Support Center